Key insights
- Stryker's Chief HR Officer, M Kathryn Fink, sold $2.47M in stock after exercising options. While the stock is near its 52-week low and considered undervalued, the insider selling could create short-term negative sentiment. However, tax obligations related to option exercises also contributed to share disposals.
M Kathryn Fink, Vice President and Chief Human Resources Officer at Stryker Corp (NASDAQ:SYK), reported a series of stock transactions, including significant sales, according to a recent filing with the Securities and Exchange Commission. The transactions, which occurred on May 8 and May 11, 2026, involved both the acquisition of shares through option exercises and the subsequent sale of common stock.The insider sales come as Stryker shares trade near their 52-week low of $281, down roughly 26% over the past year. According to InvestingPro analysis, the stock appears undervalued at current levels, with a Fair Value suggesting potential upside—placing it among companies on the most undervalued list.
On May 11, Ms. Fink sold a total of 8,720 shares of Stryker common stock, generating approximately $2,473,756. These sales took place at prices ranging from $283.453 to $283.845 per share. Of the shares sold, 5,220 were held directly, while an additional 3,500 shares were sold indirectly through the 2023 Mary Fink Living Trust, to which they had been transferred on March 26, 2026.
Prior to these sales, on May 8, Ms. Fink acquired 21,582 shares of Stryker common stock through the exercise of employee stock options. These acquisitions had a total value of approximately $3,625,387, with prices ranging from $154.14 to $179.35 per share. The options exercised were granted in February 2018 and February 2019, respectively, and were exercisable in annual increments over five years.
Also on May 8, Ms. Fink disposed of 16,362 shares of common stock at a price of $294.23 per share, totaling approximately $4,814,191. These shares were withheld to cover tax obligations related to the exercised options.
Following these transactions, Ms. Fink’s direct ownership of Stryker common stock stands at 13,137 shares. She also holds 177 shares indirectly through the 2023 Mary Fink Living Trust and 444 shares indirectly through a 401K plan. The reported direct holdings include 128 shares acquired through Stryker Corporation’s Employee Stock Purchase Plan as of March 31, 2026.For deeper insights into Stryker’s valuation and financial health, InvestingPro offers access to over 10 additional ProTips and comprehensive Pro Research Reports covering this $113 billion healthcare equipment leader.
In other recent news, Stryker Corporation reported its first-quarter 2026 earnings, which were significantly affected by a cyberattack that disrupted its operations. The company missed earnings and revenue forecasts, posting an earnings per share (EPS) of $2.60 compared to the projected $2.98, and revenue of $6 billion versus the expected $6.34 billion. Despite this setback, Stryker reaffirmed its 2026 guidance. In response to the cyber incident, Argus lowered its price target on Stryker shares from $435 to $350, although it maintained a Buy rating on the company.
Additionally, Stryker’s shareholders recently re-elected all ten members of the board of directors and approved executive pay during the annual meeting. The board members received vote totals ranging from 236.8 million to 286.2 million shares in favor. Moreover, Stryker announced a quarterly dividend of $0.88 per share, payable on July 31, 2026, marking a 4.8% increase compared to the prior year. This dividend remains unchanged from the previous quarter.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.